Neopharm

(주)네오팜 · KOSDAQ · 092730 · Industry: Manufacture of perfumes and cosmetics

Key metrics

Earnings

Revenue, Q3 2026₩39.4bn As of Sep 30, 2026 Source 1 ↗
Revenue QoQ-9.6% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Revenue YoYNot available
Operating income, Q3 2026₩10.0bn As of Sep 30, 2026 Source 1 ↗
Operating income QoQ+2.6% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Operating income YoYNot available

Share buybacks

Buyback decided, last 3 months₩0 As of Nov 19, 2026
Buyback decided, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Shares acquired, last 3 months₩0 As of Nov 19, 2026
Shares acquired, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Treasury shares cancelled, last 3 months₩0 As of Nov 19, 2026
Treasury shares cancelled (number), last 3 months0 shares As of Nov 19, 2026
Treasury shares cancelled, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Buyback decided, last 12 months₩0 As of Nov 19, 2026
Buyback decided, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Shares acquired, last 12 months₩0 As of Nov 19, 2026
Shares acquired, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Treasury shares cancelled, last 12 months₩0 As of Nov 19, 2026
Treasury shares cancelled (number), last 12 months0 shares As of Nov 19, 2026
Treasury shares cancelled, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗

Potential dilution

CB/BW/EB issued, last 12 months₩0 As of Nov 19, 2026
Rights offering new shares, last 12 months0 shares As of Nov 19, 2026
Potential new shares, last 12 months0 shares As of Nov 19, 2026
Potential new shares, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Conversion price adjustments, last 12 months0 As of Nov 19, 2026

Supply contracts

Supply contracts, last 12 months₩0 As of Nov 19, 2026
Supply contracts vs prior-year revenue0.0% As of Nov 19, 2026
Contracts without a KRW amount0 contracts without a KRW amount excluded As of Nov 19, 2026

Disclosure activity

DART filings, last 3 months3 As of Nov 19, 2026
DART filings, previous 3 months4 As of Nov 19, 2026

Insider transactions

Open-market buys, last 12 months (shares)320,400 shares As of Nov 9, 2026 Source 1 ↗, Source 2 ↗
Open-market buys, last 12 months (amount)₩7.2bn As of Nov 9, 2026 Source 1 ↗, Source 2 ↗
Open-market sells, last 12 months (shares)0 shares As of Nov 19, 2026
Open-market sells, last 12 months (amount)₩0 As of Nov 19, 2026
Net open-market buying, last 12 months (shares)320,400 shares As of Nov 9, 2026 Source 1 ↗, Source 2 ↗
Insiders who bought, last 12 months2 As of Nov 9, 2026 Source 1 ↗, Source 2 ↗

Insider transactions (last 12 months)

Open-market buys: 320,400 shares (₩7.2bn). Open-market sells: 0 shares (₩0). Net open-market buying: +320,400 shares. Insiders who bought: 2.

Trade dateInsider (role)TypeSharesPriceAmount
Nov 9, 2026IT'S HANBULCO., LTD (Controlling shareholder)Open-market buy+38,885 shares₩24,481₩952m
Nov 6, 2026IT'S HANBULCO., LTD (Controlling shareholder)Open-market buy+121,315 shares₩23,469₩2.8bn
May 4, 2026IT'S HANBULCO., LTD (Controlling shareholder)Open-market buy+60,200 shares₩21,840₩1.3bn
Apr 30, 2026IT'S HANBULCO., LTD (Controlling shareholder)Open-market buy+100,000 shares₩20,765₩2.1bn

Annual financials

YearRevenueOperating income
2025₩132.2bn₩28.8bn
2024₩119.0bn₩24.7bn
2023₩97.1bn₩25.3bn